International Osteoporosis Foundation

Medications

Review of impact of drug holidays on bone health

The impact of interruption of anti-osteoporosis treatment in patients on therapy with bisphosphonates or denosumab is reviewed in a new International Osteoporosis Foundation (IOF) working group paper 'Fracture risk following ...

page 5 from 14